Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuma Kato

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Japanese Journal of Clinical Oncology|October 22, 2025
An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortiumSatoshi Katayama, Takehiro Iwata, Shingo Nishimura, et al.
International Journal of Clinical Oncology|October 2, 2021
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN studyYoichiro Tohi, Takuma Kato, Masaki Nakamura, et al.
Japanese Journal of Clinical Oncology|October 16, 2023
Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological ConsortiumYoichiro Tohi, Takuma Kato, Keita Kobayashi, et al.
Japanese Journal of Clinical Oncology|July 27, 2023
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohortYoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
BJU International|January 29, 2026
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN studyTakuma Kato, Akira Yokomizo, Ryuji Matsumoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 4, 2025
Impact of Impaired Renal Function on the Efficacy and Safety of Second-Line Tyrosine Kinase Inhibitor Therapy After First-Line Immuno-Oncology Combination Therapy in Metastatic Renal Cell Carcinoma: A Japanese Multicenter Retrospective StudyNaoki Fujita, Yuto Matsushita, Takahiro Kojima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 25, 2022
Cancer-specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapyShintaro Narita, Naoki Terada, Kyoko Nomura, et al.
Japanese Journal of Clinical Oncology|December 26, 2025
Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological ConsortiumHideo Fukuhara, Shingo Nishimura, Keita Kobayashi, et al.
Japanese Journal of Clinical Oncology|June 27, 2025
Temporal changes in the urologist's practice behaviour of active surveillance for prostate cancer: analysis of prospective observational study cohortYoichiro Tohi, Akira Yokomizo, Ryuji Matsumoto, et al.
Scientific Reports|November 23, 2023
Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective studyTomokazu Sazuka, Yuto Matsushita, Hiroaki Sato, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Japanese Journal of Clinical Oncology|October 22, 2025
An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortiumSatoshi Katayama, Takehiro Iwata, Shingo Nishimura, et al.
International Journal of Clinical Oncology|October 2, 2021
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN studyYoichiro Tohi, Takuma Kato, Masaki Nakamura, et al.
Japanese Journal of Clinical Oncology|October 16, 2023
Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological ConsortiumYoichiro Tohi, Takuma Kato, Keita Kobayashi, et al.
Japanese Journal of Clinical Oncology|July 27, 2023
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohortYoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
BJU International|January 29, 2026
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN studyTakuma Kato, Akira Yokomizo, Ryuji Matsumoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 4, 2025
Impact of Impaired Renal Function on the Efficacy and Safety of Second-Line Tyrosine Kinase Inhibitor Therapy After First-Line Immuno-Oncology Combination Therapy in Metastatic Renal Cell Carcinoma: A Japanese Multicenter Retrospective StudyNaoki Fujita, Yuto Matsushita, Takahiro Kojima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 25, 2022
Cancer-specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapyShintaro Narita, Naoki Terada, Kyoko Nomura, et al.
Japanese Journal of Clinical Oncology|December 26, 2025
Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological ConsortiumHideo Fukuhara, Shingo Nishimura, Keita Kobayashi, et al.
Japanese Journal of Clinical Oncology|June 27, 2025
Temporal changes in the urologist's practice behaviour of active surveillance for prostate cancer: analysis of prospective observational study cohortYoichiro Tohi, Akira Yokomizo, Ryuji Matsumoto, et al.
Scientific Reports|November 23, 2023
Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective studyTomokazu Sazuka, Yuto Matsushita, Hiroaki Sato, et al.
Pageof 19